Results 191 to 200 of about 7,677,076 (348)
Development of delivery systems able to hold and release a combination of bioactive compounds at the target site represents a strategy for improving the therapeutic outcomes and overcome the central issues in the multitherapeutic approach.
Özaltin, Kadir +4 more
core
ABSTRACT Subtotal hippocampal resection can leave residual hippocampal tissue, yet the immediate postoperative electrophysiologic evolution of such remnants is unknown. We describe a patient with drug‐resistant temporal lobe epilepsy in whom a hippocampal remnant was continuously monitored using a responsive neurostimulator (RNS) following subtotal ...
Patrick Hartnett +5 more
wiley +1 more source
Focus on Barangay Economic Development [PDF]
Because the barangay is considered to be the local government unit closest to the people in terms of access and proximity, its role in local service delivery cannot be undermined. Hence, it is important for a barangay to learn how to maximize and use its
Lavado, Rouselle F. +2 more
core
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi +5 more
wiley +1 more source
Towards Establishing Shared Terminology for Person-Centred Care: A Modified Delphi Study With Consumers and Health Professionals. [PDF]
Barnden R +6 more
europepmc +1 more source
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller +14 more
wiley +1 more source
Gold nanoparticles in skin drug delivery: a bibliometric analysis of research trends from 2015 to 2025. [PDF]
Arif M, Mousa K, Butt H.
europepmc +1 more source
In oral delivery, it is often advantageous to have the onset of drug release delayed for a programmable period of time following administration. This would indeed allow the chronotherapeutic needs of several pathologies with night or early morning ...
A. Maroni
core
Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source
Scoping review of e-cigarette use in the perioperative setting: a protocol. [PDF]
Harrogate SR +4 more
europepmc +1 more source

